CClinicalTrials.gg
CompletedNCT03591341Updated Feb 1, 2019

Melatonin Degradation Rate in Human Milk

An observational study in Preterm Infant and Lactation, sponsored by Carmel Medical Center. Completed at 1 site in Israel. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-01.

Sponsored by Carmel Medical Center · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
10
Ages
18 Years and older
Sex
Female
01

Study summary

Our long term hypothesis is that giving premature infants breast milk that was pumped during the night and has high concentration of melatonin will improve outcome of several clinical conditions related to premature infants. Prior to testing this, we need to learn the pharmacokinetics of melatonin in vitro.

In this preliminary research we would like to check the levels of melatonin in breast milk pumped during the night, and evaluate the rate of degradation of the melatonin to determine the half life of melatonin in pumped breast milk (in vitro).

Read the detailed description

The study includes 10 nursing women. Each woman will bring a frozen 5 ml sample of breast milk that was pumped at 03:00 AM. The samples will be collected at the NICU department of Carmel Medical Center and will be stored at deep freeze (-20°C). The samples will be numerically coded and will be kept anonimously. After defrosting the samples, melatonin concentration will be checked in the hospital laboratory every hour, for 4 hours. If meltonin levels will be detectable after 4 hours, continous measurements will be done at 8 hours and at 12 hours after defrosting. The samples will be tested with IBL Melatonin ELISA kit. For control we will use breast milk that was pumped at 10:00 am (when melatonin excretion is minimal). At the end of the analysis the samples will be thrown away.

02

Conditions studied

  • Preterm Infant
  • Lactation

Keywords

  • melatonin
  • breast milk
03

In context

Lead sponsor

Carmel Medical Center is the lead sponsor of 112 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

healthy women who are breast feeding

Inclusion criteria

  1. Women that are breast feeding and will pump and freeze a milk sample at 03:00 AM
  2. Women at least one week after delivery

Exclusion criteria

Exclusion Criteria:

  1. A sample that will not be freezed right after the pump
  2. Women that are taking hypnotic drugs
  3. Women that are taking melatonin
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
10 participants (actual)
Patient registry
No

Groups and cohorts

  • nursing women

    women who gave birth and are breast feeding their baby- melatonin level in pumped breast milk have been checked

    Diagnostic Test: melatonin level in pumped breast milk

Interventions

  • Diagnostic testmelatonin level in pumped breast milk

    diagnostic test of melatonin level in pumped breast milk

06

What researchers measure

Primary outcomes

  1. melatonin stability in human milk

    melatonin levels in human milk samples are checked every hour after defrost

    Time frame: 24 hours

07

Study locations

1 site
  • Carmel Medical Center
    Haifa, Israel
08

References and documents

Publications

  • Cohen Engler A, Hadash A, Shehadeh N, Pillar G. Breastfeeding may improve nocturnal sleep and reduce infantile colic: potential role of breast milk melatonin. Eur J Pediatr. 2012 Apr;171(4):729-32. doi: 10.1007/s00431-011-1659-3. Epub 2011 Dec 29. PubMed 22205210 ↗
  • Katzer D, Pauli L, Mueller A, Reutter H, Reinsberg J, Fimmers R, Bartmann P, Bagci S. Melatonin Concentrations and Antioxidative Capacity of Human Breast Milk According to Gestational Age and the Time of Day. J Hum Lact. 2016 Nov;32(4):NP105-NP110. doi: 10.1177/0890334415625217. Epub 2016 Jul 10. PubMed 27121237 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 1, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03591341
Lead sponsor
Carmel Medical Center
Responsible party
Sponsor
First posted
Jul 19, 2018
Start date
Aug 1, 2017
Primary completion
Nov 30, 2017
Completion
Dec 31, 2018
Last update
Feb 1, 2019

Study contacts

michal molad, MD
principal investigator · Carmel Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion